Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.850
+0.010 (0.26%)
Sep 18, 2026, 4:08 PM HKT

HKG:2591 Stock Forecast

HKG-2591's stock price has decreased by -91.47% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, HKG:2591 stock has a consensus rating of "Strong Buy" and an average price target of $20.58. The average 1-year stock price forecast is 434.55% higher than the current stock price, while the lowest is $12.55 (+225.97%) and the highest is $28.61 (+643.12%).

Price Target: $20.58 (+434.55%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$12.55$20.58$20.58$28.61
Change+225.97%+434.55%+434.55%+643.12%
* Price targets were last updated on Jun 27, 2026.

Analyst Ratings

The average analyst rating for HKG:2591 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jul '26Aug '26
Strong Buy112222
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total112222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Guotai Haitong
No rating
Guotai Haitong
Buy
Maintains
$16.70
BuyMaintains$16.70+333.77%Jun 27, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$28.10
BuyMaintains$28.10+629.87%Apr 10, 2026

Financial Forecast

Revenue This Year
309.16M
from 131.51M
Increased by 135.08%
Revenue Next Year
763.41M
from 309.16M
Increased by 146.93%
EPS This Year
-0.43
from -0.79
EPS Next Year
-0.13
from -0.43
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--131.51M309.16M
Revenue Growth
---135.08%
Operating Income
-747.91M-189.42M-346.87M-190.17M
Net Income
-733.38M-174.69M-341.36M-191.70M
EPS
---0.79-0.43
Free Cash Flow
----267.00M
No. Analysts
---2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High397.0M
Avg309.2M
Low221.3M

Revenue Growth

Revenue Growth202620272028
High
201.9%
Avg
135.1%
Low
68.3%

EPS Forecast

EPS202620272028
High-0.34
Avg-0.43
Low-0.52

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-